Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-cash Items (2018 - 2025)

Inmune Bio (INMB) has disclosed Non-cash Items for 8 consecutive years, with $545000.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 55.25% to $545000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $545000.0 through Dec 2025, down 55.25% year-over-year, with the annual reading at $545000.0 for FY2025, 89.08% down from the prior year.
  • Non-cash Items hit $545000.0 in Q4 2025 for Inmune Bio, down from $5.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $40.6 million in Q2 2021 to a low of $545000.0 in Q4 2025.
  • Historically, Non-cash Items has averaged $10.4 million across 5 years, with a median of $9.4 million in 2022.
  • Biggest five-year swings in Non-cash Items: soared 1598.82% in 2021 and later crashed 94.34% in 2024.
  • Year by year, Non-cash Items stood at $11.2 million in 2021, then crashed by 62.9% to $4.2 million in 2022, then soared by 417.67% to $21.5 million in 2023, then plummeted by 94.34% to $1.2 million in 2024, then tumbled by 55.25% to $545000.0 in 2025.
  • Business Quant data shows Non-cash Items for INMB at $545000.0 in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q2 2025.